The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III study of adjuvant capecitabine vs observation in curatively resected stage IB (by AJCC 6th edition) gastric cancer (CATALYSIS; KCSG ST14-05).
 
Min-Hee Ryu
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
 
Jae Yong Cho
No Relationships to Disclose
 
Dae Young Zang
No Relationships to Disclose
 
Woon Kee Lee
No Relationships to Disclose
 
Keun-Wook Lee
No Relationships to Disclose
 
Dong Bok Shin
No Relationships to Disclose
 
Byung-Ho Nam
No Relationships to Disclose
 
Sung Sook Lee
No Relationships to Disclose
 
Hyun Woo Lee
No Relationships to Disclose
 
Jong Gwang Kim
No Relationships to Disclose
 
Jin-Soo Kim
No Relationships to Disclose
 
In Gyu Hwang
No Relationships to Disclose
 
Jin Ho Baek
No Relationships to Disclose
 
Chang Hak Yoo
No Relationships to Disclose
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech